Northern Trust Corp Design Therapeutics, Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 388,125 shares of DSGN stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

388,125

Previous 336,774 15.25%

Holding current value

$1.78 Million

Previous $1.81 Million 32.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.56 - $7.5 $234,160 - $385,132	51,351 Added 15.25%	388,125 $2.39 Million
Q3 2024 Nov 13, 2024	SELL	$3.19 - $5.88 $1,821 - $3,357	-571 Reduced 0.17%	336,774 $1.81 Million
Q2 2024 Aug 14, 2024	SELL	$3.23 - $4.77 $64,402 - $95,109	-19,939 Reduced 5.58%	337,345 $1.13 Million
Q1 2024 May 14, 2024	SELL	$2.27 - $4.03 $35,509 - $63,041	-15,643 Reduced 4.19%	357,284 $1.44 Million
Q4 2023 Feb 13, 2024	BUY	$1.99 - $2.76 $98,839 - $137,083	49,668 Added 15.36%	372,927 $988,000
Q3 2023 Nov 13, 2023	SELL	$2.05 - $8.14 $3,031 - $12,039	-1,479 Reduced 0.46%	323,259 $762,000
Q2 2023 Aug 11, 2023	BUY	$4.99 - $7.64 $244,360 - $374,130	48,970 Added 17.76%	324,738 $2.05 Million
Q1 2023 May 15, 2023	SELL	$5.5 - $9.77 $18,491 - $32,846	-3,362 Reduced 1.2%	275,768 $1.59 Million
Q4 2022 Feb 13, 2023	SELL	$7.86 - $17.2 $35,880 - $78,518	-4,565 Reduced 1.61%	279,130 $2.86 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $361,732 - $656,458	25,673 Added 9.95%	283,695 $4.74 Million
Q2 2022 Aug 12, 2022	BUY	$9.91 - $17.33 $465,651 - $814,302	46,988 Added 22.27%	258,022 $3.61 Million
Q1 2022 May 13, 2022	SELL	$11.17 - $20.89 $10,957 - $20,493	-981 Reduced 0.46%	211,034 $3.41 Million
Q4 2021 Feb 08, 2022	BUY	$13.64 - $21.41 $1.22 Million - $1.91 Million	89,183 Added 72.61%	212,015 $4.54 Million
Q3 2021 Nov 15, 2021	SELL	$13.99 - $20.03 $177,603 - $254,280	-12,695 Reduced 9.37%	122,832 $1.8 Million
Q2 2021 Aug 13, 2021	BUY	$19.02 - $29.78 $2.58 Million - $4.04 Million	135,527 New	135,527 $2.7 Million

Others Institutions Holding DSGN

# of Institutions

Shares Held

32.1M

Call Options Held

4.6K

Put Options Held

2.6K

View Full List

About Design Therapeutics, Inc.

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $256M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

More about DSGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Design Therapeutics, Inc. Transaction History